Print the page
Increase font size

Posted January 06, 2021

Byron King

By Byron King

Digital Gold (Or Digital Dud?)

I think any one-size-fits-all solution is crazy, a reader writes. It certainly hasnt worked well with COVID.

There are many people, including myself, who dont need any stimulus money. I am retired but my investments in IRAs and required minimum distributions plus social security more than meet my needs.

Unfortunately, Congress cannot pass any targeted legislation, and the problem is only worsened by this last-minute garbage.

Our next reader agrees: I'm seeing a troublesome trend among my friends regarding stimulus checks. People who have steady jobs and haven't been unemployed a single day are grousing about how they NEED more than $600.00.

Theyve suffered zero negative economic consequences from the pandemic, and yet feel they deserve help from the federal government. I'm concerned grown-ups are behaving like children.

Do you agree with our readers today? Have you noticed the same troublesome trend? Also, any ideas for a more targeted approach to helping hurting Americans?

Send your opinions to,

Your Rundown for Wednesday, Jan. 6, 2021

Six-Figure Bitcoin Prediction

JP Morgan made a bold bitcoin prediction Tuesday with a caveat.

No doubt youve taken note of the lofty price of bitcoin recently. In fact, the rush [has] led to bitcoin prices more than tripling in the past six months to a record peak of $34,800 on January 2, Reuters reports.

In response, JP Morgan strategists said: Bitcoins competition with gold has already started in our mind. As proof, they cited $7 billion outflows from gold and over $3 billion flooding into the Grayscale Bitcoin Trust.

Considering how big the financial investment into gold is, JP Morgan said, a crowding out of gold as an alternative currency implies big upside for bitcoin over the long term.

How much upside? JPM strategists predicted Bitcoin $146,000, adding that millennial investors might prefer digital gold over the real thing.

Ultimately, however, the JP Morgan note attributed Bitcoins most recent rally to little more than current speculative mania which doesnt speak well of the flagship digital currency, no?

We note that the spectacular bitcoin rally of the past few weeks has moved bitcoin into more challenging territory, not only in terms of its positioning backdrop, but also in terms of its valuation, JPM concluded.

Whats your Bitcoin prediction? How about your safe haven of choice? Drop us a line

Market Rundown for Wednesday, Jan. 6, 2021

S&P 500 futures are down 17 points to 3,700.

Oils up above $50 for a barrel of WTI.

Gold is down $20.90 to $1,933.50 per ounce.

Bitcoins up 1.6% to $34,240.

Send your comments and questions to,

Well be back Friday; until then, have an outstanding week.

For the Rundown,

Aaron Gentzler

Aaron Gentzler

Inflation and Supply Chain Worries Mean Opportunity

Posted June 21, 2021

By Aaron Gentzler

Today’s Rundown reviews a recent conversation we had with Editor Ray Blanco. Ray discusses semiconductors as well as inflation and supply chain worries. Then, we take a look at the markets this morning.

$1,000 Sign Up Bonus To Work Part-Time at an Arcade

Posted June 18, 2021

By Aaron Gentzler

Today we take a look at Ford’s recent run of good fortune and forecast what could come next for the stock. We also feature a reader letter about wages and the free market.
A Meme Stock ETF

A Meme Stock ETF

Posted June 16, 2021

By Aaron Gentzler

We think an ETF pegged exclusively to meme stocks must be in the works. We’re calling it now…

Novavax: Competitive Advantages ‘Boost’ Profits

Posted June 14, 2021

By Aaron Gentzler

Novavax announced its Covid-19 vaccine… So what’s next for the Maryland-based biotech company?
Make America Competitive Again

Make America Competitive Again

Posted June 11, 2021

The Senate passed the U.S. Innovation and Competition Act (USICA). The bill aspires to make America competitive again… and takes aim at China.
Biogen Breaks Through 5-Year Stalemate

Biogen Breaks Through 5-Year Stalemate

Posted June 09, 2021

“This could be a key moment for the biotech sector,” says our chief market analyst Greg Guenthner.